Neuroprotective compounds alter the expression of genes coding for proteins related to mitochondrial function in activated microglia
-
Published:2024-09
Issue:
Volume:78
Page:101934
-
ISSN:1567-7249
-
Container-title:Mitochondrion
-
language:en
-
Short-container-title:Mitochondrion
Author:
Serrano-Marín JoanORCID, Valenzuela Rita, Delgado CristinaORCID, Quijano AloiaORCID, Navarro GemmaORCID, Labandeira –García José Luis, Franco RafaelORCID
Reference39 articles.
1. Arnold, S.E., Arvanitakis, Z., Macauley-Rambach, S.L., Koenig, A.M., Wang, H.Y., Ahima, R.S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L.E., Holtzman, D.M., Nathan, D.M., 2018. Brain insulin resistance in type 2 diabetes and Alzheimer disease: Concepts and conundrums. Nat. Rev. Neurol. Doi: 10.1038/nrneurol.2017.185. 2. A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson’s disease;Bibbiani;Experimental Neurology,2003 3. Cafeína, receptores de adenosina, memoria y enfermedad de Alzheimer;Cunha;Medicina Clínica (Barcelona),2008 4. How does adenosine control neuronal dysfunction and neurodegeneration?;Cunha;Journal of Neurochemistry,2016 5. Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?;Dhananjayan;Journal of Alzheimer's Disease,2017
|
|